Hanson Pharm

Hansoh Pharma is a China-based innovation-driven pharmaceutical company that integrates drug discovery, development, manufacturing and commercialization. The group markets multiple approved products across oncology, anti-infectives, central nervous system and metabolic disease, while also advancing a broad pipeline of innovative candidates. Its R&D capabilities span small molecules, biologics, antibody-drug conjugates, peptides and siRNA, and the company reports more than 40 innovative drug candidate programs and over 70 ongoing clinical trials. Hansoh has also become increasingly active in global partnering, including licensing deals with Regeneron, MSD and GSK. The requested name "Hanson Pharm" appears to be a likely misspelling of "Hansoh Pharma" rather than the company's exact name.